R Arens, D Gozal, BC Burrell, SL Bailey, DB Bautista, TG Keens and SL Ward
Division of Neonatology and Pediatric Pulmonology, Childrens Hospital Los Angeles, University of Southern California School of Medicine 90027, USA.

Ventilatory responses to peripheral chemoreceptor stimuli are absent in patients with Prader-Willi syndrome (PWS) during wakefulness. Because arousal from sleep after rapidly developing hypoxia may require intact peripheral chemoreceptor function, we hypothesized that blunted hypoxic arousal responses during sleep Stage 3/4 would be present in PWS. Thirteen patients with PWS (mean age, 23.4 +/- 3.7 +/- SEM yr; 46% male; body mass index [BMI], 28.9 +/- 1.6 kg/m2) and 11 matched control subjects (mean age 28.0 +/- 5.4 yr; 54% male; BMI, 28.8 +/- 3.1 kg/m2) were studied. An abrupt decrease in inspired O2 tension to 80 mm Hg was introduced until arousal occurred or for a maximum of 3 min. One of the 13 patients with PWS and seven of the 11 control subjects were aroused by the hypoxic challenge (p < 0.02). During hypoxia, heart rate increased by 9 +/- 2% in the PWS group versus 22 +/- 4% in the control group (p < 0.005). Respiratory rate did not change in the PWS group (4 +/- 2%; p = NS), but it increased by 13 +/- 2% in the control group (p < 0.02). We conclude that abnormal arousal and cardiorespiratory responses to hypoxia are frequent in PWS. We postulate that intact peripheral chemoreceptor function is an important component underlying arousal mechanisms to rapidly developing hypoxia during sleep.

This article has been cited by other articles:

				A. P. Goldstone, A. J. Holland, B. P. Hauffa, A. C. Hokken-Koelega, M. Tauber, and on behalf of speakers contributors at the Second E Recommendations for the Diagnosis and Management of Prader-Willi Syndrome J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4183 - 4197. [Abstract] [Full Text] [PDF]

				P Stafler and C Wallis Prader-Willi syndrome: who can have growth hormone? Arch. Dis. Child., April 1, 2008; 93(4): 341 - 345. [Abstract] [Full Text] [PDF]

				D. A. M. Festen, A. W. de Weerd, R. A. S. van den Bossche, K. Joosten, H. Hoeve, and A. C. S. Hokken-Koelega Sleep-Related Breathing Disorders in Prepubertal Children with Prader-Willi Syndrome and Effects of Growth Hormone Treatment J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4911 - 4915. [Abstract] [Full Text] [PDF]

				S. Lee, C. L. Walker, B. Karten, S. L. Kuny, A. A. Tennese, M. A. O'Neill, and R. Wevrick Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth Hum. Mol. Genet., March 1, 2005; 14(5): 627 - 637. [Abstract] [Full Text] [PDF]

				A. M. Haqq, D. D. Stadler, R. H. Jackson, R. G. Rosenfeld, J. Q. Purnell, and S. H. LaFranchi Effects of Growth Hormone on Pulmonary Function, Sleep Quality, Behavior, Cognition, Growth Velocity, Body Composition, and Resting Energy Expenditure in Prader-Willi Syndrome J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2206 - 2212. [Abstract] [Full Text] [PDF]

				P. Burman, E. M. Ritzen, and A. C. Lindgren Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GH Endocr. Rev., December 1, 2001; 22(6): 787 - 799. [Abstract] [Full Text] [PDF]